Aurora Cannabis Inc.

ACB

CA05156X8504

Pharmaceuticals

Market Closed - Toronto S.E. Other stock markets 04:00:00 2026-02-06 pm EST			5-day change	1st Jan Change
4.770 ^CAD	+5.53%		-15.87%	-17.33%

Feb. 04	Toronto Stocks Slide; ATS Shares Rise on 3Q Beats, Bookings Rebound	DJ
Feb. 04	Aurora Cannabis Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI

Aurora Cannabis announces filing of prospectus supplement for at-the-market offering program

Published on 02/04/2026 at 09:32 am EST

Reuters

Latest news about Aurora Cannabis Inc.

Feb. 04	Toronto Stocks Slide; ATS Shares Rise on 3Q Beats, Bookings Rebound	DJ
Feb. 04	Aurora Cannabis Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
Feb. 04	Aurora Cannabis Inc., Q3 2026 Earnings Call, Feb 04, 2026
Feb. 04	Aurora Cannabis announces filing of prospectus supplement for at-the-market offering program	RE
Feb. 04	Aurora Cannabis Up In US Premarket On Q3 Revenue Beat and Bullish FY26 Expectations	MT
Feb. 04	Earnings Flash (ACB) Aurora Cannabis Inc. Reports Q3 Adjusted net income was $7.2 Million	MT
Feb. 04	Aurora Cannabis Brief: Says Maintains Strong Balance Sheet with $154.4M of Cash and Short-Term Investments, and a Debt-Free Cannabis Business	MT
Feb. 04	Aurora Cannabis Brief: Expands Q3 YoY Total Net Revenue by 7% to $94.2 Million	MT
Feb. 04	North American Morning Briefing : Software Jitters Rattle Global Markets -2-	DJ
Feb. 03	Aurora Cannabis Launches New European Websites	MT
Jan. 20	Aurora Cannabis Secures EU Community Plant Rights for Two Cannabis Varieties	MT
Jan. 20	Aurora Brief: Says Secured EU Community Plant Variety Rights for Two Proprietary Cannabis Varieties	MT
Jan. 14	Aurora Cannabis Inc. Announces Significant Progress in powdery mildew Disease Resistance Research	CI
Jan. 14	Aurora Cannabis Highlights Advances in Powdery Mildew Resistance	MT
Jan. 14	Aurora Cannabis Brief: Cites Advancements in Breeding, Testing and Production Trials For Powdery Mildew-resistant Cultivars In Cannabis Science	MT
Jan. 14	Aurora Cannabis Brief: Says Achieved "Significant Progress" in Disease Resistance Research	MT
Dec. 19	Trump Signs Executive Order to Reclassify Marijuana as Schedule III Drug; Cannabis Stocks Up Pre-Bell	MT
Dec. 18	Cannabis stocks give up gains after Trump order recommending to ease curbs on marijuana	RE
Dec. 18	Wall Street Rebounds Following Cooler-Than-Expected Consumer Inflation	MT
Dec. 18	Trump Signs Marijuana Reclassification Order, Paving Way For Medical Research	MT
Dec. 18	How US marijuana reclassification could help cannabis companies	RE
Dec. 18	Aurora Cannabis Rolls Out Daily Special Medical Cannabis Brand in Germany	MT
Dec. 18	Aurora Cannabis Launches Daily Special in Germany	MT
Dec. 18	Aurora Cannabis Brief: Announcing Launch of Daily Special, a New Medical Cannabis Brand for the German Market	MT
Dec. 17	TSX closes slightly down even as commodity stocks climb	RE

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Companyâ€™s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. It also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.

Employees

1,073

Sector

Pharmaceuticals

Calendar

Jun. 17 - Q4 2026 Earnings Release (Projected)

More about the company